A retrospective study of the management of Chinese melasma patients using a 1927 nm fractional thulium fiber laser

References

• Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–237.
   PubMed Web of Science ®Google Scholar
• Goh CL, Diova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary Dermatological Referral Centre in Singapore. Sing Med J. 1999;40:455–458.
   PubMedGoogle Scholar
• Nicolaidou E, Antoniou C, Katsambas AD. Origin, clinical presentation, and diagnosis of facial hypermelanosis. Dermatol Clin. 2007;25:321–326.
   PubMedGoogle Scholar
• Perez M, Sanchez JL, Aquilo F. Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol. 1983;81:543–545.
   PubMed Web of Science ®Google Scholar
• Lufti RJ, Fridmanis M, Misrunas AL, et al. Association of melasma with thyroid autoimmunity and other thyroid abnormalities and their relationship to the origin of melasma. J Clin Endocrinol Metab. 1985;61:28–31.
   PubMed Web of Science ®Google Scholar
• Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol. 2006;45: 285–288.
   PubMedGoogle Scholar
• Kang WH, Yoon KH, Lee ES, et al. Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–237.
   PubMed Web of Science ®Google Scholar
• Grimes P, Kelly P, Toork H, et al. Community-based trial of a triple-combination agent for the treatment of facial melasma. Cutis. 2006;77:177–184.
   PubMed Web of Science ®Google Scholar
• Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453–1457.
   PubMed Web of Science ®Google Scholar
• Wang CC, Hui CY, Sue YM, et al. Intense pulsed light for the treatment of refractory melasma in Asian patients. Dermatol Surg. 2004;30:1196–1200.
   PubMed Web of Science ®Google Scholar
• Zhou X, Gold MH, Lu Z, Li Y. Efficacy and safety of Q-switched 1064 nm neodymium-doped yttrium aluminium garnet laser treatment of melasma. Dermatol Sur. 2011;37:962–970.
   PubMed Web of Science ®Google Scholar
• Chan NPY, Ho SGY, Shek SYN, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-switched 1064 nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med. 2010;42:712–719.
   PubMed Web of Science ®Google Scholar
• Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25:121–123.
   PubMed Web of Science ®Google Scholar
• Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg. 2003;29:59–64.
   PubMed Web of Science ®Google Scholar
• Pandya AG, Hynan LS, Bhore R, et al. Reliability assessment and validity of the melasma area and severity index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64:78–83.
   PubMed Web of Science ®Google Scholar
• Hantash BM, Bedi VP, Sudireddy V, et al. Laser-induced transepidermal elimination of dermal content by fractional photothermolysis. J Biomed Opt. 2006;11:041115.
   PubMed Web of Science ®Google Scholar
• Goldberg DJ, Berlin AL, Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Laser Surg Med. 2008;40:134–138.
   PubMed Web of Science ®Google Scholar
• Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34:426–438.
   PubMed Web of Science ®Google Scholar
• Hantash BM, Mahmood MB. Fractional photothermolysis: a novel aesthetic laser surgery modality. Dermatol Surg. 2007;33:525–534.
   PubMed Web of Science ®Google Scholar
• Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg. 2008;34:301–305.
   PubMed Web of Science ®Google Scholar
• Kono T, Chan HH, Groff WF, et al. Prospective direct comparison study of fractional resurfacing using different fluences and densities for skin rejuvenation in Asians. Lasers Surg Med. 2007;39:311–314.
   PubMed Web of Science ®Google Scholar
• Chan HH, Manstein D, Yu CS, Shek S, Kono T, Wei WI. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med. 2007;39:381–385.
   PubMed Web of Science ®Google Scholar
• Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg. 2005;31:1645–1650.
   PubMed Web of Science ®Google Scholar
• Lee HS, Won CH, Lee DH, et al. Treatment of melasma in Asian skin using a fractional 1550 nm laser: an open clinical study. Dermatol Surg. 2009;35:1499–1504.
   PubMed Web of Science ®Google Scholar
• Wind BS, Kroon MW, Meesters AA, et al. Non-ablative 1550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Lasers Surg Med. 2010;42:607–612.
   PubMed Web of Science ®Google Scholar
• Karsai S, Fischer T, Pohl L, et al. Is non-ablative 1550 nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients. J Eur Acad Dermatol Venereol. 2012;26:470–476.
   PubMed Web of Science ®Google Scholar
• Sherling M, Friedman PM, Adrian R, et al. Consensus recommendations on the use of an Erbium-doped 1550-nm fractionated laser and its implications in dermatologic laser surgery. Dermatol Surg. 2010;36:461–469.
   PubMed Web of Science ®Google Scholar
• Polder K, Bruce S. Treatment of melasma using a novel 1,927nm fractional thulium fiber laser: a pilot study.Dermatol Surg. 2012;38:199–206.
   PubMed Web of Science ®Google Scholar